UNSPSC 51272202: Cyclopropane

This classification denotes an anesthetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 99TB643425. European Medicines Agency schedules Cyclopropane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06861MIG. Cyclopropane generally arises in the molecular formula C3H6. The term CYCLOPROPANE is an International Non-Proprietary Name or INN. CYCLOPROPANE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule cyclopropane under HS 29021980 and SITC 51129. As of Q4 2014, CYCLOPROPANE remains the US FDA Preferred Term for this commodity. Cyclopropane bears US NLM identifiers UMLS ID C0010587 and NCI Concept Code C81404. SMILES: C1CC1.

UNSPSC 51272202 Cyclopropane is a Commodity code that does not align with the recent state and local opportunities posted under it. The three opportunities in the recent-opportunities block solicit naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products—none of which are cyclopropane or cyclopropane-based medical gases. The code shows little relevant recent activity for its nominal scope.

Cyclopropane procurement by state and local government, when it occurs, would likely involve anesthetic or medical gas supply for hospitals, surgical facilities, or emergency departments. The mismatch between the code label and the posted opportunities suggests either a tagging error in the source data or that state and local procurement offices are not actively soliciting cyclopropane as a standalone line item under this code at present. Without opportunities that genuinely reflect cyclopropane demand, geographic concentration, issuing-body patterns, or pricing signals cannot be assessed. Business development professionals should verify with procurement offices directly whether cyclopropane is procured separately or bundled under broader medical gas or pharmaceutical supply agreements coded differently.